Noninterventional Study Assessing Cognitive Function and Physical Activity in People With Multiple Sclerosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1085 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-04-30

Study Completion Date

2017-04-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Study assessing cognitive function and physical activity in people with relapsing remitting multiple sclerosis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Physical Activity and Fatigue in Early Multiple Sclerosis (MS)

NCT00882453

Multiple Sclerosis

COMPLETED

Rehabilitation Study in MS Patients

NCT00780455

Multiple Sclerosis, Relapsing-Remitting

TERMINATED PHASE4

Assessment of Strategies for the Management of Flu-like Symptoms in MS Patients Commencing Treatment With Betaferon (INFLUENCE)

NCT01706055

Multiple Sclerosis

COMPLETED

Physical Disability in Patients Treated With Betaferon

NCT00873340

Multiple Sclerosis

COMPLETED

Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon Treatment

NCT00787657

Relapsing Remitting Multiple Sclerosis (RRMS)

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Sclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

Interferon beta-1b (Betaseron, BAY86-5046)

Intervention Type DRUG

Patients treated with regular dose subcutaneously administered, according to the label and to clinical routine practice.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Interferon beta-1b (Betaseron, BAY86-5046)

Patients treated with regular dose subcutaneously administered, according to the label and to clinical routine practice.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with Relapsing Remitting Multiple Sclerosis (RRMS), and treated with Betaferon, with the decision for treatment made at the discretion of the attending physician, documented with a prescription of Betaferon by the physician
* EDSS 0 - 6
* Written informed consent

Exclusion Criteria

* Patients who do not meet the local indication criteria for Betaferon treatment.
* Contraindications listed in the local SmPCs have to be considered.
* Patients with a history of severe head trauma.
* Patients with alcohol and/or drug abuse.
* Patients with mental retardation.
* Patients with learning disability.

Minimum Eligible Age

12 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bayer Study Director

Role: STUDY_DIRECTOR

Bayer

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Multiple Locations, , Albania

Site Status

Multiple Locations, , Algeria

Site Status

Multiple Locations, , Argentina

Site Status

Multiple Locations, , Belgium

Site Status

Multiple Locations, , Czechia

Site Status

Multiple Locations, , Egypt

Site Status

Multiple Locations, , France

Site Status

Multiple Locations, , Germany

Site Status

Multiple Locations, , Greece

Site Status

Multiple Locations, , Hungary

Site Status

Multiple Locations, , Israel

Site Status

Multiple Locations, , Kazakhstan

Site Status

Multiple Locations, , Netherlands

Site Status

Multiple Locations, , Portugal

Site Status

Multiple Locations, , Saudi Arabia

Site Status

Multiple Locations, , Tunisia

Site Status

Multiple Locations, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Albania Algeria Argentina Belgium Czechia Egypt France Germany Greece Hungary Israel Kazakhstan Netherlands Portugal Saudi Arabia Tunisia Turkey (Türkiye)